z-logo
open-access-imgOpen Access
Mortality and major morbidity in premature infants less than 31 weeks gestational age in the decade after introduction of surfactant
Author(s) -
GENZELBOROVICZÉNY ORSOLYA,
MACWILLIAMS SABINE,
VON POBLOTZKI MARTINA,
ZOPPELLI LUCIANO
Publication year - 2006
Publication title -
acta obstetricia et gynecologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.401
H-Index - 102
eISSN - 1600-0412
pISSN - 0001-6349
DOI - 10.1080/00016340500290947
Subject(s) - medicine , retinopathy of prematurity , necrotizing enterocolitis , bronchopulmonary dysplasia , gestational age , birth weight , pediatrics , population , low birth weight , mortality rate , neonatal intensive care unit , obstetrics , pregnancy , surgery , genetics , environmental health , biology
Objective. Population‐ but also center‐based mortality and major morbidity rates of premature infants are essential for prenatal counseling and quality control. Methods. Records of all infants <30 + 6 weeks ( n =674) admitted (1991–2000) to a single neonatal intensive care unit were reviewed and compared to the state‐wide mortality. Results. Six hundred and ninety‐one infants were born in or transferred to the hospital and 600 infants (89%) survived. The mean (SD) birth weight was 1018 g (±314) and the mean gestational age 27 + 5 weeks (±2.0). Mortality and morbidity did not change significantly over the 10‐year period but correlated inversely with gestational age from 45% at 230/7 weeks to 5% at 306/7 weeks. Study center mortality rate for extremely low birth weight infants with birth weight <750 g was significantly lower than reported for the entire state (local 25%; Bavaria 36% p =0.0003). Thirty‐four per cent (251/600) of the survivors had one or more major complications: intracranial hemorrhage III–IV 8% (88/600), periventricular leucomalacia 6% (41/600), bronchopulmonary dysplasia with oxygen requirement at 36 weeks 20% (128/600), necrotizing enterocolitis 6% (43/600), and retinopathy of prematurity grade III–IV 9% (55/600). Survival without major morbidity increased from 32% at 23 weeks to 92% at 30 weeks. Conclusions. Despite changes in obstetric and neonatal care during the 1990s, mortality and major morbidity rates did not change significantly after the introduction of surfactant in 1991. Comparison of local, regional, national, and international mortality and morbidity rates are becoming more important in allocating resources and in decision‐making at the limits of viability.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here